Resolution of amisulpride-associated amenorrhea by switching to aripiprazole

Psychiatry Investigation

Volumn 3, Issue 1, 2006, Pages 102-106

  Lee, Bun Hee ^a   Kim, Yong Ku ^a  

^a Korea University College of Medicine   (South Korea)

Author keywords

Amenorrhea; Amisulpride; Aripiprazole; Galactorrhea; Prolactin

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BROMOCRIPTINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; MESSENGER RNA; PROLACTIN;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC VALUE; DRUG SUBSTITUTION; FEMALE; GALACTORRHEA; HUMAN; HYPERPROLACTINEMIA; PROLACTIN BLOOD LEVEL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY;

EID: 33645675095     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Langer G, Sachar E, Gruen P, Halpern F. Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency. Nature 1977; 266 (5603):639-640.
2. Ben-Jonathan N. Dopamine: a prolactin-inhibiting hormone. Endocr Rev 1985; 6 (4):564-589.
3. Maguire GA. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psychiatry 2002: 63 (Suppl 4):56-62.
4. Haddad P, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004; 64 (20):2291-2314.
5. David S, Taylor C, Kinon B, Breier A. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clin Ther 2000; 22 (9):1085-1096.
6. Compton M, Miller A. Antipsychotic-induced hyperprolactinemia and sexual dysfunction. Psychopharmacol Bull 2002; 36 (1):143-164.
7. Dickson R, Seeman M, Corenblum B. Hormonal side effects in women: typical versus atypical antipsychotic treatment. J Clin Psychiatry 2000: 61 (Suppl 3):10-15.
8. Lee BH, Han CS, Kim KH, Kim YK. Treatment in risperidone-induced amenorrhea. Int J Psychiatry Clin Pract 2005: 9:29-34.
9. Burris K, Molski T, Xu C, Ryan E, Tottori K, Kikuchi T, Yocca F, Molinoff P. Aripiprazole, a novel antipsychotic is a high-affinity partial agonist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002: 302 (1):381-389.
10. McGavin J, Goa K. Aripiprazole. CNS Drugs 2002: 16 (11):779-786.
11. Potkin S, Saha A, Kujawa M, Carson W, Ali M, Stock E, Stringfellow J, Ingenito G, Marder S. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2003: 60 (7): 681-690.
12. Wetzel H, Wiesner J, Hiemke C, Benkert O. Acute antagonism of dopamine D2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers. J Psychiatr Res 1994; 28 (5):461-473.
13. Kopecek M, Bares M, Svarc J, Dockery C, Horacek J. Hyperprolactinemia after low dose of amisulpride. Neuro Endocrinol Lett 2004; 35 (6):419-422.
14. Kim YK, Kim L, Lee MS. Risperidone and associated amenorrhea: a report of 5 cases. J Clin Psychiatry 1999; 60 (5):315-317.
15. Jaber M, Robinson S, Missale C, Caron M. Dopumine receptors and brain function. Neuropharmacology 1996; 35 (11):1503-1519.
16. Kapur S, Langlois X, Vinken P, Megens A, Coster RD, Andrews J. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats. J Pharmacol Exp Ther 2002; 302 (3):1129-1134.
17. Bressan R, Erlandsson K, Spencer E. Ell P, Pilowsky L. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients. Psychopharmacology (Berl) 2004; 175 (3):367-373.
18. Goodnick P, Rodriguez L, Santana O. Antipsychotics: impact on prolactin levels. Expert Opin Pharmacother. 2002; 3 (10):1381-1391.
19. Anghelescu I, Wolf J. Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report. J Clin Psychiatry 2004; 65 (9):1286-1287.
20. Inoue T, Domae M, Yamada K, Furukawa T. Effects of the novel antipsychotic agent 7-(4-14-(2.3-dichlorophenyl)-1-piperazinyl]butyloxy)-3.4- dihydro-2(1H)-quinolinone (OPC-14597) on prolactin release from the rat anterior pituitary gland. J Pharmacol Exp Ther 1996; 227 (1):137-143.
21. Inoue A, Seto M, Sugita S, Hide I, Hirose T, Koga N, Kikuchi T, Nakata Y. Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary. Brain Res Mol Brain Res 1998; 55 (2):285-292.